Key Insights

Highlights

Treatment Research

6 treatments under study, led by Low Dose Radiation Therapy

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07619599Phase 1Recruiting

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Showing all 1 trials

Research Network

Common Treatments

  • Low Dose Radiation Therapy1
  • Positron Emission Tomography1
  • Stereotactic Body Radiation Therapy1
  • Computed Tomography1
  • Pembrolizumab1

Active Sponsors

  • City of Hope Medical Center1
  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Metastatic Lung Nonsmall Cell Carcinoma1
  • Metastatic Malignant Neoplasm In The Brain1
  • Stage Iv Lung Cancer Ajcc V81

Activity Timeline